相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats
Lu Luo et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2011)
CPU86017, a berberine derivative, attenuates cardiac failure through normalizing calcium leakage and downregulated phospholamban and exerting antioxidant activity
Min-you Qi et al.
ACTA PHARMACOLOGICA SINICA (2010)
ROS-Dependent Signaling Mechanisms for Hypoxic Ca2+ Responses in Pulmonary Artery Myocytes
Yong-Xiao Wang et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Local Regulation of Arterial L-Type Calcium Channels by Reactive Oxygen Species
Gregory C. Amberg et al.
CIRCULATION RESEARCH (2010)
The separate roles of endothelin receptors participate in remodeling of matrix metalloproteinase and connexin 43 of cardiac fibroblasts in maladaptive response to isoproterenol
Hong-Jun Peng et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
S-glutathionylation uncouples eNOS and regulates its cellular and vascular function
Chun-An Chen et al.
NATURE (2010)
Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy
M. Sedeek et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Role of endothelin receptor A and NADPH oxidase in vascular abnormalities
De-Zai Dai et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2010)
NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets
Kathleen E. Dennis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
The Role of NADPH Oxidase in Chronic Intermittent Hypoxia-Induced Pulmonary Hypertension in Mice
Rachel E. Nisbet et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
CPU0213, A NON-SELECTIVE ETA/ETB RECEPTOR ANTAGONIST, IMPROVES PULMONARY ARTERIOLAR REMODELING OF MONOCROTALINE-INDUCED PULMONARY HYPERTENSION IN RATS
Bing Cui et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
The use of combination therapy in pulmonary arterial hypertension: new developments
N. Galie et al.
EUROPEAN RESPIRATORY REVIEW (2009)
Chiral separation of racemate CPU86017, an anti-arrhythmic agent, produces stereoisomers possessing favourable ion channel blockade and less α-adrenoceptor antagonism
Na Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Endothelin receptor antagonist CPU0213 and vitamin E reverse downregulation of FKBP12.6 and SERCA2a:: A role of hyperphosphorylation of PKCε
Na Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Endothelin receptor antagonists in pulmonary arterial hypertension
J. Dupuis et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide
Qinghua Zeng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The positive inotropic effect of endothelin-1 is mediated by mitochondrial reactive oxygen species
V. C. De Giusti et al.
LIFE SCIENCES (2008)
CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulation
Na Li et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition
Stavros Selemidis et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from fructus corni
Wei Su et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits
Zhi-Jiang Huang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
CPU0123, a novel endothelin receptor antagonist, relieves hypoxic pulmonary hypertension in rats by suppressing excessive ET-ROS pathway
Bing Cui et al.
DRUG DEVELOPMENT RESEARCH (2007)
CPU0507, an endothelin receptor antagonist, improves rat hypoxic pulmonary artery hypertension and constriction in vivo and in vitro
Sheng-Hua Yuan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Pharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats - Mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathway
TT Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway
TT Zhang et al.
ACTA PHARMACOLOGICA SINICA (2005)
Effects of phospholemman downregulation on contractility and [Ca2+]i transients in adult rat cardiac myocytes
MA Mirza et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
分享论文
